financetom
Business
financetom
/
Business
/
Boston Scientific Insider Sold Shares Worth $517,580, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boston Scientific Insider Sold Shares Worth $517,580, According to a Recent SEC Filing
Aug 1, 2024 2:56 PM

05:40 PM EDT, 08/01/2024 (MT Newswires) -- Wendy Carruthers, Executive Vice President, Human Resources, on August 01, 2024, sold 6,983 shares in Boston Scientific ( BSX ) for $517,580. Following the Form 4 filing with the SEC, Carruthers has control over a total of 40,188 shares of the company, with 40,188 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520824007778/xslF345X03/doc4.xml

Price: 75.98, Change: +0.82, Percent Change: +1.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Monro Stock After Q4 Results?
What's Going On With Monro Stock After Q4 Results?
May 23, 2024
Monro, Inc. ( MNRO ) shares are trading lower on Thursday. The company reported fourth-quarter adjusted earnings per share of 21 cents, missing the analyst consensus of 30 cents.  Quarterly revenues of $310.08 million missed the street view of $320.239 million. Sales for the fourth quarter decreased 0.2%. “While an industry-wide deferral and trade-down cycle has lasted longer than most in our industry would...
Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment
Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment
May 23, 2024
11:36 AM EDT, 05/23/2024 (MT Newswires) -- Theriva Biologics ( TOVX ) said Thursday that the US Food and Drug Administration granted fast track designation to VCN-01 for the treatment of metastatic pancreatic cancer. VCN-01 is an oncolytic adenovirus, designed to grow and attack cancer cells, breaking down the tissue around the tumor that blocks cancer treatments, the company said....
What's Going On With Tilray Brands Stock?
What's Going On With Tilray Brands Stock?
May 23, 2024
Tilray Brands, Inc. ( TLRY ) stock is trading higher. The company on Thursday introduced a new product to its cannabis wellness brand Solei. The Details: Tilray has announced the Warming Deep Tissue Stick as the latest addition to its Solei cannabis wellness brand. The brand’s first cannabis-infused roll-on topical is focused on capturing the interest of consumers looking for a more functional,...
Tesla Omits 2030 Delivery Target From Impact Report
Tesla Omits 2030 Delivery Target From Impact Report
May 23, 2024
11:05 AM EDT, 05/23/2024 (MT Newswires) -- Tesla (TSLA) omitted its previously stated goal of building and selling 20 million vehicles per year starting in 2030 from its 2023 impact report. The company stated that objective in both its 2021 and 2022 impact reports. Price: 175.69, Change: -4.42, Percent Change: -2.45 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved